Literature DB >> 14620504

Reduced phagocytosis of colloidal carriers using soluble CD47.

Yu-Chih Hsu1, Marcela Acuña, Stanley M Tahara, Ching-An Peng.   

Abstract

PURPOSE: This study was designed to illustrate the feasibility of using soluble CD47 protein to antagonize phagocytosis of colloidal drug carriers by macrophages.
METHODS: Expression of CD47-streptavidin (CD47-SA) fusion protein was achieved in B21CodonPlus host cells following IPTG induction. Murine macrophage cell line J774A.1, expressing high levels of SIRPalpha, was selected as the biologic model system for phagocytosis. FITC-labeled perfluorocarbon (PFC) emulsions were used as the colloidal carriers to trigger phagocytosis. Microscopy (inverted light and UV-fluorescence) and flow cytometry were used to qualitatively and quantitatively determine the degree of phagocytosis, respectively.
RESULTS: The bacterially expressed, purified CD47-SA had neither cytotoxic nor cytostatic effects when incubated with J774A.1 cells up to a concentration of 400 nM for 24 h. Phagocytosis of FITC-labeled PFC emulsions was significantly diminished when macrophages were pretreated with 100 nM CD47-SA for 1 h.
CONCLUSIONS: We demonstrated that soluble CD47-SA antagonized phagocytosis of colloidal carriers to a significant degree by interaction with macrophage SIRPalpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14620504     DOI: 10.1023/a:1026114713035

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

Review 1.  Blood substitutes.

Authors:  Robert M Winslow
Journal:  Curr Opin Hematol       Date:  2002-03       Impact factor: 3.284

Review 2.  Long-circulating and target-specific nanoparticles: theory to practice.

Authors:  S M Moghimi; A C Hunter; J C Murray
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

3.  Diminution of phagocytosed perfluorocarbon emulsions using perfluoroalkylated polyethylene glycol surfactant.

Authors:  Y C Hsu; C A Peng
Journal:  Biochem Biophys Res Commun       Date:  2001-05-18       Impact factor: 3.575

4.  Role of CD47 as a marker of self on red blood cells.

Authors:  P A Oldenborg; A Zheleznyak; Y F Fang; C F Lagenaur; H D Gresham; F P Lindberg
Journal:  Science       Date:  2000-06-16       Impact factor: 47.728

5.  Biodistribution, metabolism, and in vivo gene expression of low molecular weight glycopeptide polyethylene glycol peptide DNA co-condensates.

Authors:  W T Collard; Y Yang; K Y Kwok; Y Park; K G Rice
Journal:  J Pharm Sci       Date:  2000-04       Impact factor: 3.534

6.  Chemical characterization of fluorescein isothiocyanate-protein conjugates.

Authors:  A Jobbágy; K Király
Journal:  Biochim Biophys Acta       Date:  1966-07-27

7.  Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv).

Authors:  S Dübel; F Breitling; R Kontermann; T Schmidt; A Skerra; M Little
Journal:  J Immunol Methods       Date:  1995-01-27       Impact factor: 2.303

8.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes.

Authors:  A L Klibanov; K Maruyama; V P Torchilin; L Huang
Journal:  FEBS Lett       Date:  1990-07-30       Impact factor: 4.124

9.  High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages.

Authors:  A Veillette; E Thibaudeau; S Latour
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

10.  CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis.

Authors:  P A Oldenborg; H D Gresham; F P Lindberg
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

View more
  12 in total

1.  Small molecule-gold nanorod conjugates selectively target and induce macrophage cytotoxicity towards breast cancer cells.

Authors:  Erik C Dreaden; Sandra C Mwakwari; Lauren A Austin; Matthew J Kieffer; Adegboyega K Oyelere; Mostafa A El-Sayed
Journal:  Small       Date:  2012-07-06       Impact factor: 13.281

2.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

Review 3.  Engineering antiphagocytic biomimetic drug carriers.

Authors:  Alicia Sawdon; Ching-An Peng
Journal:  Ther Deliv       Date:  2013-07

4.  Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance.

Authors:  Joshua Kim; Sauradeep Sinha; Melani Solomon; Edgar Perez-Herrero; Janet Hsu; Zois Tsinas; Silvia Muro
Journal:  Biomaterials       Date:  2017-09-06       Impact factor: 12.479

5.  Surface functionalization of gold nanoparticles with red blood cell membranes.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Brian T Luk; Jing Su; Liangfang Zhang
Journal:  Adv Mater       Date:  2013-05-27       Impact factor: 30.849

6.  Perfluorohexane-loaded macrophages as a novel ultrasound contrast agent: a feasibility study.

Authors:  Liselotte M Kornmann; Daniëlle M J Curfs; Evelien Hermeling; Ingeborg van der Made; Menno P J de Winther; Robert S Reneman; Koen D Reesink; Arnold P G Hoeks
Journal:  Mol Imaging Biol       Date:  2008-06-07       Impact factor: 3.488

7.  'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach.

Authors:  Che-Ming J Hu; Ronnie H Fang; Brian T Luk; Kevin N H Chen; Cody Carpenter; Weiwei Gao; Kang Zhang; Liangfang Zhang
Journal:  Nanoscale       Date:  2013-04-07       Impact factor: 7.790

8.  Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood.

Authors:  Jiahe Li; Charles C Sharkey; Dantong Huang; Michael R King
Journal:  Cell Mol Bioeng       Date:  2015-02-24       Impact factor: 2.321

9.  CD47 on artificial structures.

Authors:  Christian Schütz
Journal:  Aging (Albany NY)       Date:  2015-08       Impact factor: 5.682

Review 10.  The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?

Authors:  Zahra Beizavi; Seyed Mohammad Gheibihayat; Hadis Moghadasian; Hossein Zare; Babak Shirazi Yeganeh; Hassan Askari; Sina Vakili; Amir Tajbakhsh; Amir Savardashtaki
Journal:  Mol Biol Rep       Date:  2021-07-17       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.